Feasibility and Outcomes of Endovascular Aneurysm Repairs (EVARs) Without Arterial Line Monitoring
NCT ID: NCT06491589
Last Updated: 2024-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2024-08-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC
NCT00226629
Endovascular Aneurysm Repair (EVAR) Gate Study
NCT02934087
Enhanced Guidance for Endovascular Repair of Abdominal Aortic Aneurysm
NCT01824654
Pre-emptive Abdominal Aortic Aneurysm Sac Embolization During EVAR
NCT05575570
REGISTRY for the Use of a Software for Automatic Detection of the Evolution of Aneurysmal Volume and Graft Migration After EVAR (EndoVascular Aneurysm Repair)
NCT05964348
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Endovascular Aneurysm Repair (EVAR) has been pivotal in this transformation, providing minimally invasive alternatives to traditional open surgery. Unlike conventional approaches, EVAR involves repairing aneurysms without a large laparotomy incision and aortic clamping, using instead stent grafts delivered from within the vessel to reinforce weakened sections of the aorta. This method offers numerous advantages over conventional surgery, including reduced surgical trauma and shorter recovery times. Historically, EVARs required general anesthesia and bilateral femoral surgical exposure. However, recent innovations, such as percutaneously inserted lower-profile devices and the use of local anesthesia, have further simplified the procedure, mitigating the complexities associated with general anesthesia induction and maintenance.
Usually, following the patient's entry into the operating room for an EVAR procedure, they are provided with an arterial line. Arterial lines ('art' lines) allow continuous monitoring of blood pressure, providing beat-to-beat measurements. They also offer a convenient method for obtaining arterial blood samples, eliminating the need for multiple needle punctures. Despite their utility, arterial lines carry potential complications (incidence rate of 1% for both minor and major complications across radial, femoral, and axillary artery cannulations among adult patients), including infection, thrombosis, vasospasm, hematoma formation, and air embolism. Inserting an arterial line also extends the procedure time, contingent on factors such as patient anatomy and physician expertise. Patient perception of arterial lines may vary, with some finding the insertion uncomfortable, particularly during initial placement and securing.
At our institution, standard EVARs are preferentially performed with a "simplest practice possible" approach. This idea removes any unnecessary instrumentation of the patient, while still prioritizing patient safety. Our approach so far includes omitting urinary catheterization, employing a percutaneous approach and performing the surgery under local anesthesia. In an effort to advance our understanding and optimize patient care, our institution has explored the possibility of EVARs without arterial line monitoring. Through collaborative discussions involving surgical, anesthesia, and nursing teams, patients deemed candidates have undergone EVAR procedures without arterial monitoring. In cases where beat-to-beat monitoring was necessary intra-operatively, a transducer connected to the femoral arterial sheath was used to provide information equivalent to traditional arterial lines. Similarly, if an arterial blood sample was required, it was obtained directly from the arterial sheath.
This novel approach, though not yet described in literature, holds promise for improving procedural efficiency and patient outcomes. Omitting arterial lines could potentially streamline procedures, enhance patient satisfaction, and reduce complication risks associated with arterial access. Reforming standard-of-care paradigms, whether in clinic or operating room, is a well-established practice in medicine. A similarly innovative approach was undertaken by the Vancouver Heart Team for transcatheter aortic valve replacement (TAVR) procedures. They developed a standardized clinical pathway for safe early discharge after TAVR. Following implementation, retrospective analysis revealed that patients discharged early exhibited more favorable clinical indicators compared to those with standard discharge protocols. This study, one among many, illustrates how simplifying procedures and care standards, while maintaining patient safety, can achieve positive outcomes.
However, several critical questions remain unanswered, including the impact on operating time, complication rates, and acceptance by the treating teams. As such, this proposal seeks to address these uncertainties by investigating the feasibility and outcomes of EVARs without arterial line monitoring. By systematically evaluating this approach, we aim to optimize patient care pathways and enhance procedural efficiency.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
EVAR with arterial line monitoring
No interventions assigned to this group
Group B
EVAR with no arterial line monitoring
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients requiring fenestrated endografts: these are more complex cases, take a longer duration, usually require a general anesthetic and are at higher risk of arterial rupture, and thus cannot safely be performed without an arterial line.
* Patients undergoing EVAR with an Endologix endograft: there is a small risk of anaphylaxis with the polymer used with the Endologix endograft, and thus the arterial line is required for beat-to-beat monitoring during graft deployment.
* Patients with heavily calcified iliac or femoral arteries: this increases the risk of arterial rupture, and thus requires beat-to-beat arterial monitoring.
* Absence of significant co-morbidities: no severe aortic stenosis (AS) (suspected AS and echo diagnostic criteria: max jet velocity \>4.0 m/s, mean gradient \>40 mmHg, valve area \<1 cm²); No congestive heart failure (CHF) (CHF diagnostic criteria: ejection fraction (EF) below 50% and natriuretic (NT) pro-Brain Natriuretic Peptide (BNP) levels based on the following age-adjusted cutoff limits.
* Age \< 50 years: NT pro-BNP greater than 450 ng/L.
* Age 50-75 years: NT pro-BNP greater than 900 ng/L.
* Age \> 75 years: NT pro-BNP greater than 1800 ng/L.); Blood pressure below 180/120 on the morning of the operation day; Surgeon and/or anesthesiologist discretion.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Loukman Ghouti
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Loukman Ghouti
Role: PRINCIPAL_INVESTIGATOR
Dalhousie University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QEII Health Sciences Center
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Dunn K, Jessula S, Herman CR, Smith M, Lee MS, Casey P. Safety and effectiveness of single ProGlide vascular access in patients undergoing endovascular aneurysm repair. J Vasc Surg. 2020 Dec;72(6):1946-1951. doi: 10.1016/j.jvs.2020.03.028. Epub 2020 Apr 8.
Jessula S, Cote C, Khoury M, DeCarlo C, Bellomo TR, Grant-Gorveatt A, Herman C, Smith M, Dua A, Eagleton M, Casey P, Zacharias N. Local Anesthesia for Endovascular Repair of Abdominal Aortic Aneurysm Allows for Accurate Graft Deployment with Durable Results. Ann Vasc Surg. 2024 May;102:64-73. doi: 10.1016/j.avsg.2023.11.033. Epub 2024 Jan 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1030377
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.